NCT03669315View on ClinicalTrials.gov

Modulating Inhibitory Control Networks in Gambling Disorder With Theta Burst Stimulation

PHASE3RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 20, 2018

Primary Completion Date

December 1, 2019

Study Completion Date

December 1, 2019

Conditions
Gambling Disorder
Interventions
DEVICE

Transcranial Magnetic stimulation

Neuromodulation tool

Trial Locations (1)

50100

RECRUITING

CNSOnlus, Institute of Neuroscience, Florence

All Listed Sponsors
lead

CNS Onlus

OTHER

NCT03669315 - Modulating Inhibitory Control Networks in Gambling Disorder With Theta Burst Stimulation | Biotech Hunter | Biotech Hunter